Ongoing research into nutritional and exercise interventions, as well as novel pharmacological agents such as myostatin/activin pathway inhibitors (243) or agents targeting the apelin pathway (244) holds promise for preserving lean mass and improving overall health in patients undergoing treatment with GLP-1 and dual GIP/GLP-1 receptor agonists
They are both usually administered as weekly injections
Every time I open Instagram, it seems to only take a few seconds of scrolling for me to be served a post for a GLP-1 medication like Ozempic, Wegovy, or Zepbound
Long-acting agents (e.g., semaglutide weekly, dulaglutide weekly) provide sustained receptor activation, improving both fasting and postprandial glucose
I think there are many people who are using it as a marketing tool because they want people to think youre not on a full dose of a GLP-1, she says
So that would be interesting